The Rest Of Latin America Medical Device Contract Manufacturing Market was valued at $149.8 Million in 2025 and projected to reach to $250.7 Million by 2030, representing a compound annual growth rate of 10.8%. The Medical Device Contract Manufacturing Market is experiencing significant expansion, driven by increasing demand for specialized manufacturing capabilities, cost optimization strategies, and regulatory compliance expertise.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The Medical Device Contract Manufacturing Market is projected to grow from $83.96 billion in 2025 to $140.84 billion by 2039, representing a robust CAGR of 10.9%.
North America is the fastest-growing region with an 11.4% CAGR, driven by advanced healthcare infrastructure, regulatory expertise, and increasing outsourcing adoption.
The market analysis covers multiple segments including Device types, Device Classes, and Services across all major global regions including Europe, Asia Pacific, Latin America, and Middle East & Africa.
The 14-year forecast period (2025-2039) provides strategic insights for long-term business planning and investment decisions in the contract manufacturing sector.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
End-to-end CDMO for regulated devices leveraging ISO 13485 medical sites and 14 FDA-registered facilities to execute complex injection molding, precision plastics, electronics integration, and automated assembly at global scale. | Accelerates time-to-market with vertically integrated plastics, PCBA, systems build, and digital supply chain that de-risks components across thousands of suppliers and millions of parts, enabling rapid scale-up with compliance built in. |
|
|
Contract development and manufacturing for Class II/III devices, instruments, and capital equipment with design engineering and lifecycle services across medical devices, orthopedics, and diagnostics. | Reduces cost and complexity through vertically integrated manufacturing and global execution, supporting complex catheter, RAS, and chronic care products while maintaining a patient-focused quality culture. |
|
|
Specialized medical device outsourcing with design-through-manufacture of interventional, cardiovascular, and neuromodulation devices plus batteries and catheters for OEM programs. | Enhances program success through deep domain know-how and vertically integrated capabilities that minimize risk and speed product transfers for high-reliability implantables and minimally invasive platforms. |
|
|
Turnkey design, build, and service of complete medical systems including imaging, diagnostics, surgical robotics, and high-volume disposables via ISO 13485 network with FDA-registered sites and NPI facilities worldwide. | Improves reliability and uptime with integrated PCB/PCBA, systems assembly, testing, and global repair/refurbishment, enabling lifecycle support and rapid regional transfers under validated processes. |
|
|
Concept-to-market outsourcing with proven FDA Class II/III experience, providing product development, regulatory, manufacturing, and aftermarket services for complex devices across imaging, monitoring, and therapeutics. | Shortens commercialization cycles via full value-stream solutions, robust transition teams, and global compliance to scale efficiently while mitigating supply risks. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DRUG DELIVERY DEVICES (Device) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10.9% from 2025 to 2030 |
| Largest Segment | DEVICE DEVELOPMENT & MANUFACTURING SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 83.96 (2025) |
| Revenue Forecast (Billions) | ~USD 140.84 (2030) |
| Segments Covered | Device, Type, Device Class, Service |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EIKEN CHEMICAL CO., LTD. | Japan | Public Company | Fecal immunochemical test (FIT) reagents for colorectal cancer screening,Microbiological reagents (media, antimicrobial susceptibility, rapid tests),Urinalysis test strips (occult blood, protein, glucose), |
| CYIENT | India | Public Company | Digital, Engineering & Technology,Design Led Manufacturing,Others (Networks, Operations, and Adjacent Services), |
| JABIL INC. | United States | ||
| FLEX LTD. | Singapore | Public Company | Integrated Technology Solutions (ITS),Regulated Manufacturing Solutions (RMS),Cloud and Power Infrastructure (CPI), |
| PLEXUS CORP. | United States | Public Company | Healthcare/Life Sciences EMS and Design Services,Aerospace/Defense EMS and Engineering,Industrial/Commercial EMS and Sustaining Services, |
| SANMINA CORPORATION | United States | Public Company | Integrated Manufacturing Solutions (design-to-delivery EMS),Components, Products and Services, |
| INTEGER HOLDINGS CORPORATION | United States | Public Company | Cardiac Rhythm Management & Heart Failure (devices, leads, power solutions),Neuromodulation (spinal cord stimulators and related components),Cardio & Vascular / Interventional (cardiology, structural heart, peripheral, neurovascular, oncology), |
| CELESTICA INC. | Canada | Public Company | Connectivity and Cloud Solutions,Advanced Technology Solutions, |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Proprietary Products – stoppers, seals, syringe and cartridge components,Proprietary Products – drug containment systems, self-injection devices, and integrated services,Contract-Manufactured Products – devices and assemblies, |
| RECIPHARM AB | Sweden | Private Company | Advanced Delivery Systems (ADS – inhalation, devices, integrated drug–device),Manufacturing Steriles (MFG-S – injectables, lyophilisation, blow-fill-seal),Manufacturing Solids & Others (MFG-SO – tablets, capsules, semi-solids, liquids, powders), |
| KIMBALL ELECTRONICS, INC. | United States | Public Company | Automotive electronics and assemblies,Medical EMS and contract manufacturing (disposables, drug delivery),Industrial and other electronics manufacturing, |
| NORTECH SYSTEMS, INC. | United States | Public Company | Electromedical devices and imaging assemblies,Electromechanical and industrial systems/box builds,Wire and cable assemblies, |
| CARCLO PLC | United Kingdom | Public Company | In vitro diagnostics and medical consumables,Drug delivery components and assemblies,Aerospace and safety cables and systems, |
EIKEN CHEMICAL CO., LTD. is a Japanese public company founded in 1939 with 696 employees. The company operates in the chemical manufacturing sector.
CYIENT is an Indian public company founded in 1991 with 12,049 employees. The company provides engineering, design, and technology services across multiple industries.
Insufficient data provided for business description.
FLEX LTD. is a Singapore-based public company founded in 1969 with 149,686 employees. The company is a global electronics manufacturing services provider.
PLEXUS CORP. is a United States-based public company founded in 1979 with 20,000 employees. The company provides electronics manufacturing services and specialized solutions.
SANMINA CORPORATION is a United States-based public company founded in 1980 with 35,000 employees. The company is a global provider of electronics manufacturing services and supply chain solutions.
INTEGER HOLDINGS CORPORATION is a United States-based public company founded in 1970 with 11,000 employees. The company manufactures medical devices and components for the healthcare industry.
CELESTICA INC. is a Canadian public company founded in 1994 with 23,803 employees. The company provides electronics manufacturing services and supply chain solutions globally.
WEST PHARMACEUTICAL SERVICES, INC. is a United States-based public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for the pharmaceutical and healthcare industries.
RECIPHARM AB is a Swedish private company founded in 1994 with 6,752 employees. The company provides pharmaceutical manufacturing and development services.
KIMBALL ELECTRONICS, INC. is a United States-based public company founded in 1961 with 5,700 employees. The company provides electronics manufacturing services and solutions.
NORTECH SYSTEMS, INC. is a United States-based public company founded in 1990 with 699 employees. The company provides electronics manufacturing and engineering services.
CARCLO PLC is a United Kingdom-based public company founded in 1924 with 907 employees. The company manufactures precision-engineered components and assemblies for various industries.
Rest Of Latin America's medical device contract manufacturing market is valued at $149.8 million in 2025.
Rest Of Latin America's market is forecast to reach $250.7 million by 2030, growing at a 10.8% CAGR.
Rest Of Latin America's growth is driven by rising healthcare investments, regulatory modernization, cost competitiveness, skilled labor availability, and regional market proximity.
Rest Of Latin America's manufacturers are expanding in diagnostics, orthopedics, and cardiovascular devices, among other high-value categories.
Rest Of Latin America offers cost advantages, improving regulatory frameworks, skilled workforce, quality compliance capabilities, and strategic proximity to major healthcare markets.
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the medical device contract manufacturing market. This approach also helped identify key industry players and enabled classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments from both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers; presidents; CEOs; vice presidents; chairpersons; chief operating officers; chief strategy officers; directors; chief information officers; and chief medical information officers in the medical device contract manufacturing market.
A breakdown of the primary respondents is provided below:
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION

Note 1: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION

To know about the assumptions considered for the study, download the pdf brochure
We determined the total size of the medical device contract manufacturing market by triangulating data from three approaches, as described below. After each approach, we calculated a weighted average of the three approaches based on the level of assumptions used in each approach.

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, where applicable, to complete the overall market engineering process and arrive at exact statistics for all segments and subsegments.
The medical device contract manufacturing market refers to the outsourcing of medical device-related activities, including design and development, prototyping, component manufacturing, assembly, testing, packaging, and other value-added manufacturing services, to specialized third-party contract manufacturers by medical device OEMs, pharmaceutical and drug delivery companies, diagnostic companies, and other healthcare companies.
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to 5)
Further breakdown of the Rest of Europe market into Ireland, Switzerland, Poland, Belgium, Austria, and Sweden; the Rest of Asia Pacific market into Singapore, Malaysia, Taiwan, Thailand, Vietnam, and Indonesia; and the Rest of Latin America market into Argentina, Colombia, Chile, and Costa Rica.
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the medical device contract manufacturing market
Full forecast, segment splits, and company analysis for all Medical Device Contract Manufacturing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report